Dr. Ng-Cashin is Novotech’s Chief Medical Officer (CMO), leading the company’s Therapeutic & Scientific Strategy, Quality Assurance, and Drug Development Consulting functions. She joined Novotech in 2023, bringing more than 20 years of international experience across pharmaceutical, biotech, and CRO environments. Based in the United States, Judith provides strategic medical leadership across global programs and multi-regional trials, ensuring scientific integrity and high-quality delivery for clients and patients. She has held senior executive roles at Syneos Health, INC Research, Quintiles, Eagle Pharmaceuticals, AoBiome, and GlaxoSmithKline.
Judith Ng-Cashin is a part of the Novotech.
Learn More
